Condition

MCI-AD, Early Stage Alzheimer's Disease clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Lecanemab in Early to Moderate Alzheimer's Disease using Multi-omics data

  This study tests whether Lecanemab can help people with early-to-moderate Alzheimer's disease and uses multiple biological data types to understand its effects.

  Recruiting Phase 4 First Affiliated Hospital of Wenzhou Medical University · Wenzhou, Zhejiang · NCT07604896

• Testing dimethyl fumarate for improving cognitive functions in Alzheimer's patients

  This study is testing if a medication called dimethyl fumarate can help improve memory and thinking skills in older adults with mild cognitive impairment and early-stage Alzheimer's disease.

  Recruiting Phase 2 Medical University of Lodz · Lodz, Łódź Voivodeship · NCT06850597

Related topics

Quick answers

How many MCI-AD, Early Stage Alzheimer's Disease clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →